LONDON, May 5, 2011 /PRNewswire/ -- Elsevier, the world-leading publisher of scientific, technical and medical information products and services, announces the launch of Exam Consult, an online exam preparation and simulation tool. The first of several online question banks planned for 2011, the initial release offers preparation for the challenging medical finals exams.
Exam Consult offers students the opportunity to prepare with questions closely matched to their curriculum, written by expert contributors and assessed by a panel of experts ( http://www.examconsult.co.uk/examconsult/contributors.cfm). John Rees, Head of Medical Education and Dean of Undergraduate Education at King's College London School of Medicine has been heavily involved with the creation of Exam Consult and offers the following assurance, "As an external examiner for two UK Medical Schools, I know the types of questions asked and Exam Consult really offers realistic finals practice, with a mix of single-best answer questions and extended-matching questions for all disciplines."
Further, Exam Consult allows students to identify their areas of weakness by system, discipline, competence and in comparison to peers. This detailed analysis of results is uniquely available with Exam Consult and allows students to tailor their preparation, therefore maximizing efficiency. Students can further address their weak areas with targeted learning provided by trusted Elsevier brands, including Kumar & Clark's Clinical Medicine, Davidson's Principles and Practice of Medicine and the Crash Course series.
Feedback from students demonstrates Exam Consult is well received by students, "Easy to use and fully comprehensive - excellent preparation for Finals exams," 5th year medical student, Newcastle University.
A free 7-day trial of Exam Consult is available at http://www.examconsult.co.uk. Full subscriptions are available for 3 months, 6 months or 12 months. For subscriptions or further information, please visit http://www.examconsult.co.uk.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys (https://www.reaxys.com/info/), MD Consult (http://www.mdconsult.com/php/240581084-199/homepage) and Nursing Consult (http://www.nursingconsult.com/php/240586898-10/home.html), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review ( http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Tom Reller VP, Corporate Relations, Elsevier T.Reller@elsevier.com +1-215-239-3508